MARTHA MILLER

CGCN GROUP, LLC · Washington, DC · registered since 2024

Registered · LDAActive

Send proposal →Contact →Claim this profile →

At a glance

Registered since

2024

Senate LDA system

Clients

last 3 years

Filings

2 agencies contacted

Activity

filings by quarter

Works on

Trade (domestic/foreign) 22 Budget/Appropriations 21 Taxation/Internal Revenue Code 20 Health Issues 18 Energy/Nuclear 12 Banking 12 Financial Institutions/Investments/Securities 12 Disaster Planning/Emergencies 11 Homeland Security 10 Fuel/Gas/Oil 9 Environment/Superfund 9 Defense 9 Labor Issues/Antitrust/Workplace 8 Education 8 Science/Technology 7 Computer Industry 6 Consumer Issues/Safety/Products 6 Natural Resources 6 Insurance 6 Clean Air and Water (quality) 5 Copyright/Patent/Trademark 4 Housing 4 Manufacturing 4 Communications/Broadcasting/Radio/TV 4 Tobacco 3 Aviation/Airlines/Airports 3 Immigration 3 Retirement 3 Small Business 2 Foreign Relations 2 Intelligence 2 Law Enforcement/Crime/Criminal Justice 2 Economics/Economic Development 2 Transportation 1 Alcohol and Drug Abuse 1 Automotive Industry 1 Chemicals/Chemical Industry 1 Telecommunications 1 Torts 1 Accounting 1

Background

Government experience

Deputy Director of Scheduling

Sen. Ted Cruz (TX), 2019-2020; Scheduler, Rep. Warren Davidson (OH-08), 2020-2022.

Disclosed on LD-2 filings

Deputy Director of Scheduling

Sen. Ted Cruz (TX), 2019-2020;Scheduler, Rep. Warren Davidson (OH-08), 2020-2022.

Disclosed on LD-2 filings

Career

CGCN GROUP, LLC

Washington, DC

2024 - present

Specific issues

Supporting advocacy on hospitality issues.

Small Business · 2024 Q1

Reauthorization of Pandemic and All-Hazards Preparedness and Advancing Innovation Act Funding for medical countermeasure enterprise including, Strategic National Stockpile (SNS), Biomedical Advanced Research and Development Authority (BARDA), and Project BioShield for FY25 Naloxone access and awareness legislation State opioid response (SOR) Grant funding for FY25 Substance Abuse and Mental Health Block Grant (SABG) funding and FY25 NDAA for Fiscal Year 2024 and Fiscal Year 2025 - provisions related to biological and chemical defense and access to naloxone HANDS Act - H.R. 5506 SAVE Act of 2023 - H.R. 6161 Overdose Reversal Medication (ORM) Act - H.R. 6243 Workplace Overdose Reversal Kits (WORK) to Save Lives Act - H.R. 5420, S.2948 School Access to Naloxone Act of 2023 - H.R. 3065, S. 2946 Protecting Kids from Fentanyl Act of 2023 - H.R. 4582 Saving Lives in Schools Act of 2023 - H.R. 4240

Homeland Security · 2024 Q3

Domestic law enforcement access to digital evidence generally, and specifically, H.R. 3089 - NDO Fairness Act.

Law Enforcement/Crime/Criminal Justice · 2024 Q3

Issues pertaining to Workforce Development and retraining issues.

Education · 2024 Q3

Issues pertaining to intellectual property rights including, but not limited to, patent protection and enforcement, copyright protection and enforcement in international markets.

Issues pertaining to market access for software products and services in international markets including, but not limited to, provisions related to intellectual property protection and market access for software products and services. Issues pertaining to international trade agreements including, but not limited to, provisions relating to IP protection and enforcement, electronic commerce, services and government procurement.

Trade (domestic/foreign) · 2024 Q3